Shalby profit and loss

Latest FY26

Revenue: ₹1,141cr+5.0% on FY25
EBITDA: ₹143cr+7.7% on FY25
Net profit: ₹34.7cr+1,706.6% on FY25
EPS: ₹3.23+1,694.4% on FY25

₹ crore except per share

Tap a line for its trend	Last 12Mto Jun 2026	FY26Mar 2026	FY25Mar 2025	FY24Mar 2024	FY23Mar 2023	FY22 and earlierAlpha Plus

Expenses
	1,176	1,141	1,087	934	805	FY22 and earlierEvery year the company has filed comes with Alpha Plus.
	27.2	26.8	27.6	19.4	22.5
	1,203	1,168	1,115	953	827
	57.6	64.8	92.7	32.0	170
	147	134	104	76.2	72.3
	−27.4	−47.4	−82.0	−44.6	−45.9
	190	188	185	155	144
	40.2	39.0	38.7	16.0	9.1
	72.2	70.0	65.8	52.2	48.1
	667	659	655	538	328
	1,146	1,108	1,059	825	725
	143	143	133	177	137
	70.6	72.8	66.8	125	88.7
Profit
	57.6	60.6	55.7	128	102
	57.6	60.6	55.7	128	102
	37.6	44.0	56.5	59.6	35.5
	−17.5	−18.1	−2.7	−14.9	−1.1
	20.1	25.9	53.8	44.7	34.4
	37.5	34.7	1.9	83.5	67.7
	37.5	34.7	1.9	83.5	67.7
	−23.8	−24.7	−2.6	0.6	1.1
	13.7	10.0	−0.7	84.1	68.8
	39.3	37.4	6.2	—	67.7
	−1.8	−2.7	−4.3	—	−0.0
Per share
	₹3.50	₹3.23	₹0.18	₹7.78	₹6.31
	₹3.50	₹3.23	₹0.18	₹7.77	₹6.27
Other comprehensive income — detail
	−23.8	−24.7	−2.6	—	—
	−6.9	0.2	−0.1	0.6	0.4
	−0.1	−0.0	−0.1	—	—
	—	—	—	0.0	0.1
	—	−24.9	—	—	0.9
	—	0.0	2.6	—	—
	—	12.6	3.6	84.1	68.8
	—	−2.7	−4.3	−0.6	−0.0
Per share — as-filed variants
	₹3.50	₹3.23	₹0.00	₹7.78	₹6.31
	₹3.50	₹3.23	₹0.00	₹7.77	₹6.27
	₹0.00	₹0.00	₹0.18	₹0.00	₹0.00
	₹0.00	₹0.00	₹0.18	₹0.00	₹0.00
Derived — gross profit (revenue − materials − purchases − Δ inventories)
	999	990	972	870	609
	85.0%	86.7%	89.5%	93.2%	75.6%
Adjusted (ex-exceptional items) — derived
	57.6	60.6	55.7	128	102
	37.5	34.7	1.9	83.5	67.7
	₹3.50	₹3.23	₹0.18	₹7.78	₹6.31

Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

alphave

SHALBY₹112.10

Shalby Limited

· Pharma & Health

Annual Quarterly₹ CrorePeersGKSL GPTHEALTH INDRAMEDCO ARTEMISMED LOTUSEYE DRAGARWQ KMCSHIL KOVAIMcap ₹1,205 Cr

View

In ₹ Crore except Per Share 12 Months Ending	FY23 31/03/2023	FY24 31/03/2024	FY25 31/03/2025	FY26 31/03/2026	Last 12M 30/06/2026
Revenue from Operations	804.9	933.7	1,087.0	1,141.4	1,176.2
Other Income	22.5	19.4	27.6	26.8	27.2
Total Income	827.4	953.2	1,114.6	1,168.2	1,203.4
Expenses
+ Cost of Materials Consumed	169.9	32.0	92.7	64.8	57.6
+ Purchases of Stock-in-Trade	72.3	76.2	103.9	133.9	146.6
+ Changes in Inventories	-45.9	-44.6	-82.0	-47.4	-27.4
+ Employee Benefit Expense	143.6	155.4	184.6	188.3	189.6
+ Finance Costs	9.1	16.0	38.7	39.0	40.2
+ Depreciation & Amortisation	48.1	52.2	65.8	70.0	72.2
+ Other Expenses	328.3	537.7	655.2	659.1	667.0
Total Expenses	725.4	825.0	1,058.8	1,107.7	1,145.8
EBITDA	136.7	177.0	132.6	142.8	142.8
EBIT	88.7	124.8	66.8	72.8	70.6
Profit
PBT before Exceptional Items	102.0	128.2	55.7	60.6	57.6
Pretax Income	102.0	128.2	55.7	60.6	57.6
+ Current Tax	35.5	59.6	56.5	44.0	37.6
+ Deferred Tax	-1.1	-14.9	-2.7	-18.1	-17.5
Tax Expense	34.4	44.7	53.8	25.9	20.1
Net Income	67.7	83.5	1.9	34.7	37.5
+ Net Income — Continuing Ops	67.7	83.5	1.9	34.7	37.5
+ Other Comprehensive Income	1.1	0.6	-2.6	-24.7	-23.8
Total Comprehensive Income	68.8	84.1	-0.7	10.0	13.7
Net Income to Common	67.7	—	6.2	37.4	39.3
Minority Interest	-0.0	—	-4.3	-2.7	-1.8
Per Share
Basic EPS	6.31	7.78	0.18	3.23	3.50
Diluted EPS	6.27	7.77	0.18	3.23	3.50
Other Comprehensive Income — detail
+ Other Comprehensive Income	—	—	-2.6	-24.7	-23.8
+ Items NOT to be Reclassified to P&L	0.4	0.6	-0.1	0.2	-6.9
+ Tax on Items NOT to be Reclassified	—	—	-0.1	-0.0	-0.1
+ Tax on Items NOT to be Reclassified — alt tag	0.1	0.0	—	—	—
+ Items to be Reclassified to P&L	0.9	—	—	-24.9	—
+ Tax on Items to be Reclassified	—	—	2.6	0.0	—
Comprehensive Income — Owners of Parent	68.8	84.1	3.6	12.6	—
Comprehensive Income — Non-controlling Interests	-0.0	-0.6	-4.3	-2.7	—
Per Share — as-filed variants
Basic EPS — Continuing Operations	6.31	7.78	0.00	3.23	3.50
Diluted EPS — Continuing Operations	6.27	7.77	0.00	3.23	3.50
Basic EPS — Discontinued Operations	0.00	0.00	0.18	0.00	0.00
Diluted EPS — Discontinued Operations	0.00	0.00	0.18	0.00	0.00
Derived — Gross Profit (Revenue − Materials − Purchases − Δ Inventories)
Gross Profit	608.7	870.2	972.3	990.1	999.4
Gross Margin %	75.62	93.19	89.46	86.74	84.97
Adjusted (ex-Exceptional Items) — derived
Pretax Income (Adjusted, as filed)	102.0	128.2	55.7	60.6	57.6
Net Income Adj (tax-effected)	67.7	83.5	1.9	34.7	37.5
EPS Adj	6.31	7.78	0.18	3.23	3.50
Other Filed Concepts — mapped but not yet placed in the schedule
Face Value	10.00	10.00	10.00	10.00	10.00
Paid Up Equity Capital	107.3	107.4	107.5	107.5	107.5

As filed, sign as filed — read the label, not the sign. A line appears only when the company tagged that concept in at least one period shown, so depth follows the filer: pre-Ind-AS, insurance and NBFC blocks stay hidden unless they were actually reported. Alternate tags for the same idea (e.g. two spellings of a deferred-tax element) are kept as separate lines rather than merged, because merging them would be a guess. Ratios, per-share figures and counts render as raw numbers, not ₹ Crore. No consensus estimates → no Est columns. Click any row to chart it.

« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave

Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.